ApprovalTrail

Approval · Notice of Compliance 35804 · 2025

SIMPONI: Notice of Compliance 35804

Issued August 7, 2025

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
35804
Date
August 7, 2025
Company
Janssen Inc.Toronto, Ontario, Canada
Product type
Biologic
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Product Monograph update

Products in this notice

BrandDINStatus today
SIMPONINot yet assigned—
SIMPONI I.V.Not yet assigned—

Medicinal ingredients